Phase 2 Lymphopenia Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia
Idiopathic CD4 Lymphopenia
National Institute of Allergy and Infectious Diseases (NIAID)60 enrolled1 locationNCT05600920
Recruiting
Phase 2
Evaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid Tumors
Solid CancerLymphopenia
Second Affiliated Hospital of Soochow University127 enrolled1 locationNCT07258160